Pfizer's PF-08046052: A Significant Milestone in Clinical Development. LAVA Therapeutics N.V., a leader in the biotechnology sector, has recently announced a significant clinical development milestone achieved by Pfizer for the drug PF-08046052. This milestone has prompted the first payment of $7 million to LAVA, marking a notable event in the field of immuno-oncology.$ラバ セラピューティックス(LVTX.US)$ https://stockregion.app/p/biotech-leader-announces-7m-milestone
Trytosaveabitスレ主Be a voice no echo:
Ok! But your prediction of pattern going back up don’t look as if it’s working out so well! GL and I hope im wrong!
ラバ セラピューティックスに関するコメント
LAVA Therapeutics N.V., a leader in the biotechnology sector, has recently announced a significant clinical development milestone achieved by Pfizer for the drug PF-08046052. This milestone has prompted the first payment of $7 million to LAVA, marking a notable event in the field of immuno-oncology. $ラバ セラピューティックス(LVTX.US)$
https://stockregion.app/p/biotech-leader-announces-7m-milestone
まだコメントはありません